Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
Market Closed
2 Mar, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
15. 30
+0.13
+0.86%
$
1.26B Market Cap
- P/E Ratio
- Div Yield
1,691,381 Volume
- Eps
$ 15.17
Previous Close Day Range
14.43 15.48
Year Range
2.6 17.49
Want to track AMLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AMLX earnings report is expected in 29 days (1 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.23 | 0.07 |
| | | 0.43 | - |
AMLX Earnings Reports FAQ
What is the earnings per share (EPS) for AMLX?
EPS data for AMLX is currently not available, as Amylyx Pharmaceuticals, Inc. Common Stock has not reported recent earnings.
What is the company's earnings growth rate?
Amylyx Pharmaceuticals, Inc. Common Stock has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-03, based on the AMLX's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Amylyx Pharmaceuticals, Inc. Common Stock are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AMLX at this time, as Amylyx Pharmaceuticals, Inc. Common Stock has no recent EPS data to calculate it.
